APA (7th ed.) Citation

Capra, R., Morra, V. B., Mirabella, M., Gasperini, C., Scandellari, C., Totaro, R., . . . Patti, F. (2021). Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results. Neurological Sciences, 42(7), 2837. https://doi.org/10.1007/s10072-020-04838-z

Chicago Style (17th ed.) Citation

Capra, Ruggero, et al. "Natalizumab Is Associated with Early Improvement of Working Ability in Relapsing-remitting Multiple Sclerosis Patients: WANT Observational Study Results." Neurological Sciences 42, no. 7 (2021): 2837. https://doi.org/10.1007/s10072-020-04838-z.

MLA (9th ed.) Citation

Capra, Ruggero, et al. "Natalizumab Is Associated with Early Improvement of Working Ability in Relapsing-remitting Multiple Sclerosis Patients: WANT Observational Study Results." Neurological Sciences, vol. 42, no. 7, 2021, p. 2837, https://doi.org/10.1007/s10072-020-04838-z.